These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 29295643)

  • 41. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
    Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
    Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, immunophenotypic, and genetic analysis of adult lymphomas with morphologic features of Burkitt lymphoma.
    Haralambieva E; Boerma EJ; van Imhoff GW; Rosati S; Schuuring E; Müller-Hermelink HK; Kluin PM; Ott G
    Am J Surg Pathol; 2005 Aug; 29(8):1086-94. PubMed ID: 16006805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ongoing mutations in the N-terminal domain of c-Myc affect transactivation in Burkitt's lymphoma cell lines.
    Albert T; Urlbauer B; Kohlhuber F; Hammersen B; Eick D
    Oncogene; 1994 Mar; 9(3):759-63. PubMed ID: 8108117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clinicopathologic characteristics of Burkitt-like lymphoma with chromosome 11q aberration].
    Wei P; Zhang YL; Xie JL; Zheng YY; Liu W; Zhou XG
    Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):176-179. PubMed ID: 29534356
    [No Abstract]   [Full Text] [Related]  

  • 46. Genetic differences between paediatric and adult Burkitt lymphomas.
    Havelange V; Pepermans X; Ameye G; Théate I; Callet-Bauchu E; Barin C; Penther D; Lippert E; Michaux L; Mugneret F; Dastugue N; Raphaël M; Vikkula M; Poirel HA
    Br J Haematol; 2016 Apr; 173(1):137-44. PubMed ID: 26887776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genomic instability in mouse Burkitt lymphoma is dominated by illegitimate genetic recombinations, not point mutations.
    Rockwood LD; Torrey TA; Kim JS; Coleman AE; Kovalchuk AL; Xiang S; Ried T; Morse HC; Janz S
    Oncogene; 2002 Oct; 21(47):7235-40. PubMed ID: 12370814
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma.
    Yoon JW; Gallant M; Lamm ML; Iannaccone S; Vieux KF; Proytcheva M; Hyjek E; Iannaccone P; Walterhouse D
    Mol Cancer Res; 2013 Jun; 11(6):604-15. PubMed ID: 23525267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
    Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
    Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis.
    Chapman CJ; Wright D; Stevenson FK
    Leuk Lymphoma; 1998 Jul; 30(3-4):257-67. PubMed ID: 9713958
    [TBL] [Abstract][Full Text] [Related]  

  • 52. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
    Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
    Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Submicroscopic genomic imbalances in Burkitt lymphomas/leukemias: association with age and further evidence that 8q24/MYC translocations are not sufficient for leukemogenesis.
    Lundin C; Hjorth L; Behrendtz M; Ehinger M; Biloglav A; Johansson B
    Genes Chromosomes Cancer; 2013 Apr; 52(4):370-7. PubMed ID: 23225516
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols.
    Rohde M; Richter J; Schlesner M; Betts MJ; Claviez A; Bonn BR; Zimmermann M; Damm-Welk C; Russell RB; Borkhardt A; Eils R; Hoell JI; Szczepanowski M; Oschlies I; Klapper W; Burkhardt B; Siebert R; ;
    Genes Chromosomes Cancer; 2014 Nov; 53(11):911-6. PubMed ID: 25044415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Burkitt lymphoma in adults.
    Linch DC
    Br J Haematol; 2012 Mar; 156(6):693-703. PubMed ID: 21923642
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature.
    Quesada AE; Liu H; Miranda RN; Golardi N; Billah S; Medeiros LJ; Jaso JM
    Hum Pathol; 2016 Oct; 56():101-8. PubMed ID: 27257042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
    Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
    Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reconstructing clonal evolution in relapsed and non-relapsed Burkitt lymphoma.
    Reutter K; Sandmann S; Rohde J; Müller S; Wöste M; Khanam T; Michgehl U; Klapper W; Wößmann W; Seggewiß J; Lenz G; Dugas M; Burkhardt B
    Leukemia; 2021 Feb; 35(2):639-643. PubMed ID: 32404974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.